Google Übersetzer
Niagen Bioscience, Inc.
About
Niagen Bioscience, Inc. (NASDAQ:NAGE) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 22 2026
Niagen Bioscience to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026
Apr 9 2026
Niagen Bioscience Collaborates with USP to Establish First-Ever USP Monograph for Nicotinamide Riboside Chloride (NRCl), the Patented Form in Niagen®
Mar 31 2026
Niagen Bioscience Announces First Cruise Ship Clinic Partnership with OneSpaWorld, Bringing the NAD-Boosting Benefits of Niagen IV to the High Seas
Mar 19 2026
Niagen Bioscience Increases Share Repurchase Program to $20 Million
Mar 18 2026
Niagen Bioscience to Present at the 38th Annual ROTH Conference
Financials
Revenue
$129.42 M
Market Cap
$350.75 M
P/E Ratio
21.90
EPS
0.20